Abstract
The nocturnal melatonin (MLT) surge is a relevant oncostatic signal for a variety of experimental malignancies.
Population studies support the hypothesis that exposure to light at night may represent a new risk factor for breast cancer possibly through the suppression of pineal MLT production and/or circadian disruption.
We tested the ability of constant light exposure to suppress MLT production in female nude rats and stimulate the growth of tissue-isolated MCF-7 human breast cancer xenografts via increased tumor linoleic acid (LA) metabolism.
Rats maintained on an alternating light/dark cycle (L:D group) exhibited a robust circadian MLT rhythm that was abolished following constant light exposure. During the exposure of animals bearing tissue-isolated human MCF-7 breast cancer xenografts to constant light, the rate of tumor growth markedly increased relative to the L:D group. Tumor LA uptake and its metabolism to the mitogen 13-hydroxyoctadecadienoic acid (13-HODE) were also substantially higher under constant light conditions.
This is the first biological evidence for a potential link between constant light exposure and increased human breast oncogenesis involving MLT suppression and stimulation of tumor LA metabolism.
See also:
- Official Web Site: The Di Bella Method;
- About Melatonin - In vitro, review and in vivo publications;
- The Di Bella Method (A Fixed Part - Bromocriptine/Cabergoline);
- Complete objective response to biological therapy of plurifocal breast carcinoma.